Enovis (ENOV) vs Polaris (PII)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Polaris (PII) has outperformed Enovis (ENOV) over the past year, gaining 0.2% versus a loss of 11.5%. Over five years, PII leads with a -46.6% price change compared with -69.5% for ENOV. Polaris is the larger company by market cap ($3.63 billion vs $1.47 billion), about 2.5 times the size, while Enovis is growing revenue faster (+6.7% vs -0.3%).
On valuation, Enovis trades at a lower forward P/E (7.4x vs 20.4x for Polaris). Polaris pays a dividend yielding 4.25%, while Enovis does not currently pay one. Polaris converts more of its revenue into profit, with a net margin of -6.5% versus -52.7%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ENOV | PII |
|---|---|---|
| Share price | $25.47 | $63.73 |
| Market cap | $1.47B | $3.63B |
| 1-day change | -2.90% | -1.12% |
| YTD return | -4.39% | +0.76% |
| 1-year return | -11.47% | +0.19% |
| 5-year return | -69.49% | -46.60% |
| Forward P/E | 7.35 | 20.36 |
| EPS (TTM) | $-9.23 | $-3.67 |
| Dividend yield | 0.00% | 4.25% |
| Annual dividend | $0.00 | $2.71 |
| Revenue (latest FY) | $2.25B | $7.15B |
| Revenue growth (YoY) | +6.66% | -0.33% |
| Net income (latest FY) | $-1.18B | $-465.50M |
| Gross margin | 59.84% | 19.14% |
| Operating margin | -50.01% | -4.88% |
| Net margin | -52.69% | -6.51% |
| 52-week high | $31.67 | $77.98 |
| 52-week low | $16.70 | $47.14 |
| Distance from 52-week high | -19.58% | -18.27% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +48.53% | +1.88% |
| Average volume | 1.71M | 828.69K |
| Shares outstanding | 57.69M | 56.93M |
| Employees | 7,802 | 14,500 |
| Sector | Health Care | Consumer Discretionary |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Polaris is about 2.5 times larger than Enovis by market value ($3.63B vs $1.47B).
- PII has outperformed ENOV by 11.7 percentage points over the past year.
- Polaris offers a meaningfully higher dividend yield (4.25% vs 0.00%).
- Polaris is more profitable, keeping -6.5 cents of every revenue dollar as net income versus -52.7 cents for Enovis.
- Enovis grew revenue faster in its latest fiscal year (+6.66% vs -0.33%).
- The two companies sit in different sectors: Enovis in Health Care and Polaris in Consumer Discretionary.
About Enovis
ENOV stock →Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments.
Health Care · Industrial Specialties · 7,802 employees
About Polaris
PII stock →Polaris Inc. designs, engineers, manufactures, and markets powersports vehicles in the United States, Canada, and internationally.
Consumer Discretionary · Industrial Specialties · 14,500 employees
ENOV vs PII FAQ
Which is bigger, Enovis or Polaris?
Polaris (PII) is larger, with a market capitalization of $3.63B compared with $1.47B for Enovis (ENOV).
Which stock has performed better over the past year, ENOV or PII?
PII returned +0.19% over the past 12 months, compared with -11.47% for ENOV (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Enovis or Polaris?
Polaris pays a dividend yielding 4.25%, while Enovis does not currently pay a regular dividend.
Are Enovis and Polaris in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.